The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.
New study provides insights into the factors that influence treatment adherence in Latin America and the Caribbean. Results show that individuals from lower resource settings often achieve higher levels of adherence, contrary to predictions.
Concerns have been raised about the shortage of antiretroviral drugs available for people living with HIV in Venezuela, which is in the midst of a mounting health crisis.
People living with HIV in Peru have demanded the Minister of Health, Aníbal Velásquez Valdivia, to declare the need for antiretroviral medication a national interest, and to lift the monopoly on medication, making it possible to buy generic treatment at a much lower price. Currently the US pharmaceutical company Brystol-Myers-Squibb has a government monopoly on the provision of the antiretroviral treatment Atazanavir, meaning the government is unable to buy any other treatment brand.